{
    "code": "01027718",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01027718",
    "time": "2015-11-20 03:12:41",
    "許可證字號": "衛署藥製字第027718號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/07\/18",
    "發證日期": "73\/07\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00102771805",
    "中文品名": "臨得隆注射液４公絲\/公撮（貝皮質醇）",
    "英文品名": "RINDERON INJECTION 4MG\/ML (BETAMETHASONE)",
    "適應症": "外科休克類似休克狀態、腦浮腫、副腎腫瘍摘除、關節風濕症、急性副腎不全、支氣管氣喘、風濕熱、結核性胸膜炎、結核性髓膜炎、腦脊髓炎、濕疹、天？瘡類、圓形脫毛症、過敏性結膜炎、鞏膜炎、虹彩炎、虹彩毛樣體炎、過敏性鼻炎、複合性副鼻腔炎。",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "BETAMETHASONE DISODIUM PHOSPHATE",
    "限制項目": [
        "01國產"
    ],
    "申請商名稱": "1410301200  台灣塩野義製藥股份有限公司",
    "申請商地址": "台北市南京東路二段２號４樓",
    "主製造廠": {
        "製造廠名稱": "0402602300  中國化學製藥股份有限公司新豐工廠",
        "製造廠廠址": "新竹縣新豐鄉坑子口１８２之１號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30043200002 含有腎上腺皮質類固醇荷爾蒙，其衍生物及結構式類似者Containing adrenal corticosteroid hormones, their derivatives and structural analogues",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6804000230",
            "成分名稱": "BETAMETHASONE DISODIUM PHOSPHATE",
            "含量描述": "(5.3MG) 4",
            "含量": "",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "01027718-102-12-24.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027718&Seq=001&Type=9"
        },
        {
            "title": "RD-INJ Box-104-09-22.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027718&Seq=001&Type=8"
        }
    ]
}